Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lienna Y. Chan"'
Autor:
Xiaolin Jia, Shu Cao, Alexandra S. Lee, Monali Manohar, Sayantani B. Sindher, Neera Ahuja, Maja Artandi, Catherine A. Blish, Andra L. Blomkalns, Iris Chang, William J. Collins, Manisha Desai, Hena Naz Din, Evan Do, Andrea Fernandes, Linda N. Geng, Yael Rosenberg-Hasson, Megan Ruth Mahoney, Abigail L. Glascock, Lienna Y. Chan, Sharon Y. Fong, CLIAHUB Consortium, Chan Zuckerberg Biohub, Maira Phelps, Olivia Raeber, Stanford COVID-19 Biobank Study Group, Natasha Purington, Katharina Röltgen, Angela J. Rogers, Theo Snow, Taia T. Wang, Daniel Solis, Laura Vaughan, Michelle Verghese, Holden Maecker, Richard Wittman, Rajan Puri, Amy Kistler, Samuel Yang, Scott D. Boyd, Benjamin A. Pinsky, Sharon Chinthrajah, Kari C. Nadeau
Publikováno v:
JCI Insight, Vol 7, Iss 13 (2022)
BACKGROUND Prolonged symptoms after SARS-CoV-2 infection are well documented. However, which factors influence development of long-term symptoms, how symptoms vary across ethnic groups, and whether long-term symptoms correlate with biomarkers are poi
Externí odkaz:
https://doaj.org/article/29fb8b337be04e9387a9661b78bef2c0
Autor:
Joachim Justad Røise, Hesong Han, Jie Li, D. Lucas Kerr, Chung Taing, Kamyar Behrouzi, Maomao He, Emily Ruan, Lienna Y. Chan, Eli M. Espinoza, Sören Reinhard, Kanav Thakker, Justin Kwon, Mohammad R. K. Mofrad, Niren Murthy
Publikováno v:
Molecular Pharmaceutics. 19:67-79
The development of endosomal disruptive agents is a major challenge in the field of drug delivery and pharmaceutical chemistry. Current endosomal disruptive agents are composed of polymers, peptides, and nanoparticles and have had limited clinical im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bf013634aa8279954fcce57e9e85ce4
https://doi.org/10.1021/acs.molpharmaceut.1c00579
https://doi.org/10.1021/acs.molpharmaceut.1c00579
Autor:
Alex Espinosa, Vida Ahyong, Joseph L. DeRisi, Minh Phuong Nguyen, Cristina M. Tato, Lienna Y. Chan, Wesley Wu, Amy Kistler, Karan D. Bhatt, Norma Neff, Andreas S. Puschnik, Debra A. Wadford, Joshua Batson, Sabrina A Mann, Steve Miller, Patrick Ayscue, David Dynerman, Simon Paul, Sidney M Bell, Manu Vanaerschot, Emily D. Crawford, James T. Webber, Angela M. Detweiler, Jack Kamm, John Bell, Michelle Tan, Si Noon Hong
Publikováno v:
Journal of Clinical Microbiology
Since April 7, 2020, our COVID-19 diagnostic laboratory (CLIAHUB) has received samples from multiple counties in California - our RT-PCR protocol (1) employs N-gene (NIID_2019-nCov_N_F2/R2ver3/P2 (Japan) (2)) and E-gene (E_Sarbeco_F/R/P1 (Germany) (3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09abaeb09acb14a67cfcc93553d9297f
Autor:
Manu Vanaerschot, David Dynerman, Amy Kistler, Simon Paul, Norma Neff, Joshua Batson, Angela M. Detweiler, James T. Webber, Jack Kamm, Michelle Tan, Alex Espinosa, Debra A. Wadford, Emily D. Crawford, Wesley Wu, Andreas S. Puschnik, Vida Ahyong, Karan D. Bhatt, Si Noon Hong, John Bell, Joseph L. DeRisi, Cristina M. Tato, Sabrina A Mann, Patrick Ayscue, Sidney M Bell, Steve Miller, Minh Nguyen, Lienna Y. Chan
We identify a mutation in the N gene of SARS-CoV-2 that adversely affects annealing of a commonly used RT-PCR primer; epidemiologic evidence suggests the virus retains pathogenicity and competence for spread. This reinforces the importance of using m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b6dea16efcf10ad87e6ad1575608cbe
https://doi.org/10.1101/2020.08.25.265074
https://doi.org/10.1101/2020.08.25.265074
